In addition, liraglutide was found to repair the cognitive impairment in a rat model of PCOS by inhibiting the overexpression of the Notch signaling pathway (165)
What Are the Potential Side Effects of This Triple Agonist The most commonly reported adverse effects in clinical studies are gastrointestinal, consistent with the GLP-1 receptor agonist class
Heres how peptide therapy differs: Its designed to support repair , not just mask symptoms It may reduce reliance on frequent anti-inflammatories It can complement physical therapy, rehab, strength training, and mobility work It focuses on helping the body shift into a more effective healing state If you want a recovery plan that supports the source of the problemnot just temporary reliefthis is often where peptides fit
REFERENCES British Menopause Society incretin therapies and HRT NICE tirzepatide guidance NHS England tirzepatide guidance MHRA GLP1 safety guidance Mayo Clinic report on hormone therapy and tirzepatide findings NICE tirzepatide guidance NHS England tirzepatide guidance MHRA GLP1 safety guidance Mayo Clinic report on hormone therapy and tirzepatide findings
Two visual companions to Eps Ind A, and one visual companion to DI Tuc, are identified: (1) is Eps Ind Ab, (2) is the background star Gaia DR3 6412595290591430784 (also identified in the Spitzer 8 m observations of the background field) and (3) is the background star Gaia DR3 6411654761473726464 in the field of the DI Tuc observations
indicated that GLP-1RAs treatment might increase the risk of thyroid cancer, with the risk demonstrating an upward trend with prolonged usage of the medication (13 years and longer) [4]
